Qiang Li Selected Research

Platinum

12/2023	A novel model to predict the risk of hematological toxicity in lung adenocarcinoma patients with pemetrexed plus platinum chemotherapy based on real-world data.
5/2022	Prediction of response and adverse drug reaction of pemetrexed plus platinum-based chemotherapy in lung adenocarcinoma by serum metabolomic profiling.
1/2022	Low profile visualized intraluminal support stent-assisted Hydrocoil embolization for acutely ruptured wide-necked intracranial aneurysms: A propensity score-matched cohort study.
1/2022	Effects of Radiotherapy on Survival of Esophageal Cancer Patients Receiving Immunotherapy: Propensity Score Analysis and Nomogram Construction.
1/2021	A pharmacogenetics study of platinum-based chemotherapy in lung cancer: ABCG2 polymorphism and its genetic interaction with SLC31A1 are associated with response and survival.
5/2018	Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation.
1/2017	Association between polymorphisms of autophagy pathway and responses in non-small cell lung cancer patients treated with platinum-based chemotherapy.
1/2017	Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer.
10/2016	RICTOR polymorphisms affect efficiency of platinum-based chemotherapy in Chinese non-small-cell lung cancer patients.
5/2016	Effects of Platinum Nanocolloid in Combination with Gamma Irradiation on Normal Human Esophageal Epithelial Cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiang Li Research Topics

Disease

478	Neoplasms (Cancer) 05/2024 - 04/2002
142	Inflammation (Inflammations) 05/2024 - 07/2003
103	Infections 04/2024 - 01/2003
90	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 02/2006
85	Neoplasm Metastasis (Metastasis) 05/2024 - 06/2005
72	Type 2 Diabetes Mellitus (MODY) 12/2023 - 08/2005
65	Lung Neoplasms (Lung Cancer) 03/2024 - 04/2002
60	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 02/2003
59	Hypertension (High Blood Pressure) 03/2024 - 07/2007
53	Hypoxia (Hypoxemia) 03/2024 - 01/2003
48	Wounds and Injuries (Trauma) 05/2024 - 01/2003
47	Carcinogenesis 04/2024 - 09/2007
45	Breast Neoplasms (Breast Cancer) 11/2023 - 04/2006
43	Fibrosis (Cirrhosis) 10/2023 - 01/2012
41	Stomach Neoplasms (Stomach Cancer) 05/2024 - 01/2006
40	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 12/2008
39	Carcinoma (Carcinomatosis) 01/2023 - 10/2003
38	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 11/2008
38	Stroke (Strokes) 05/2024 - 11/2009
38	Aneurysm (Aneurysms) 01/2024 - 02/2009
37	COVID-19 01/2024 - 01/2020
34	Insulin Resistance 03/2024 - 05/2007
32	Obesity 05/2024 - 05/2007
32	Ischemic Stroke 02/2024 - 02/2014
30	Body Weight (Weight, Body) 12/2023 - 03/2010
30	Pain (Aches) 09/2023 - 11/2010
27	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 05/2007
26	Non-alcoholic Fatty Liver Disease 02/2024 - 04/2011
25	Necrosis 02/2024 - 01/2007
25	Thrombosis (Thrombus) 02/2024 - 06/2010
23	Hemorrhage 04/2024 - 01/2014
23	Chronic Hepatitis B 01/2023 - 06/2007
22	Acute Lung Injury 01/2024 - 01/2010
22	Myocardial Infarction 12/2023 - 12/2008
22	Chronic Renal Insufficiency 01/2023 - 04/2017
21	Heart Failure 05/2024 - 11/2009
21	Adenocarcinoma of Lung 04/2024 - 11/2002
21	Tuberculosis (Tuberculoses) 01/2024 - 12/2005
20	Diabetes Mellitus 12/2023 - 01/2010
19	Glioma (Gliomas) 05/2024 - 01/2004
19	Melanoma (Melanoma, Malignant) 04/2024 - 02/2007
19	Acute Kidney Injury (Acute Renal Failure) 02/2024 - 08/2008
18	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 12/2012
18	Infarction (Infarctions) 10/2023 - 01/2011
18	Pneumonia (Pneumonitis) 02/2023 - 05/2006
18	Pathologic Constriction (Stenosis) 01/2023 - 12/2005
17	Intracranial Aneurysm (Cerebral Aneurysm) 02/2024 - 05/2014
17	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2024 - 02/2015
17	Coronary Artery Disease (Coronary Atherosclerosis) 09/2023 - 11/2007
17	Heroin Dependence (Heroin Abuse) 07/2023 - 09/2010
17	Liver Cirrhosis (Hepatic Cirrhosis) 02/2023 - 03/2008
16	Asthma (Bronchial Asthma) 01/2024 - 02/2004
16	Brain Injuries (Brain Injury) 11/2023 - 08/2013

Drug/Important Bio-Agent (IBA)

181	Proteins (Proteins, Gene)FDA Link 05/2024 - 02/2003
102	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2003
78	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2006
66	MicroRNAs (MicroRNA)IBA 03/2024 - 01/2010
66	Messenger RNA (mRNA)IBA 02/2024 - 07/2008
63	CytokinesIBA 02/2024 - 11/2004
50	Therapeutic UsesIBA 05/2024 - 01/2004
44	Long Noncoding RNAIBA 04/2024 - 01/2015
42	LipidsIBA 10/2023 - 05/2007
37	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 06/2002
36	RNA (Ribonucleic Acid)IBA 02/2024 - 02/2006
33	EnzymesIBA 04/2024 - 11/2004
33	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 03/2004
27	Interleukin-6 (Interleukin 6)IBA 02/2024 - 11/2004
26	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 02/2006
25	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 11/2002
25	CarbonIBA 12/2023 - 08/2007
25	Circular RNAIBA 11/2023 - 01/2018
25	Small Interfering RNA (siRNA)IBA 01/2023 - 12/2007
24	AntioxidantsIBA 01/2024 - 03/2005
24	Insulin (Novolin)FDA Link 02/2022 - 01/2009
23	Transcription Factors (Transcription Factor)IBA 04/2024 - 01/2003
21	LipopolysaccharidesIBA 02/2024 - 10/2006
21	CalciumIBA 01/2023 - 01/2003
19	Alanine Transaminase (SGPT)IBA 02/2024 - 11/2007
19	Peptides (Polypeptides)IBA 01/2024 - 10/2009
18	SaltsIBA 05/2024 - 12/2015
18	Interleukin-10 (Interleukin 10)IBA 02/2024 - 03/2009
18	PlatinumIBA 12/2023 - 07/2012
17	Triglycerides (Triacylglycerol)IBA 03/2024 - 07/2007
17	CreatinineIBA 02/2024 - 07/2007
17	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 11/2011
17	Antiviral Agents (Antivirals)IBA 12/2023 - 06/2007
17	Phosphotransferases (Kinase)IBA 01/2023 - 11/2011
16	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 07/2008
16	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2004
16	Uric Acid (Urate)IBA 01/2024 - 07/2007
16	IonsIBA 01/2024 - 07/2008

Therapy/Procedure

240	Therapeutics 05/2024 - 03/2002
81	Drug Therapy (Chemotherapy) 04/2024 - 03/2002
69	Stents 01/2024 - 06/2004
47	Radiotherapy 04/2024 - 06/2004
34	Immunotherapy 05/2024 - 03/2006
23	Length of Stay 01/2024 - 06/2007
20	Transplantation 01/2023 - 09/2005
17	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2023 - 06/2009
16	Percutaneous Coronary Intervention 08/2023 - 12/2008